Romosozumab Loop
Targeted sclerostin inhibitor fragment analyzed for systemic osteoblast pathway stimulation.
Open Romosozumab Loop in the 3D analyzerAnalytical specification
| Empirical formula | Complex antibody fragment loop mapping |
|---|---|
| Molecular weight | 149 kDa (Full) |
| Isoelectric point (pI) | 8.80 |
| Assay purity (HPLC) | 99.10% |
| Retention time | 7.20 min |
| Peak area / height | 15400 / 1190 |
| Reference batch | RO-2026-E12 |
| Research category | Immune, Solvents & Others |
| Amino-acid sequence | Sclerostin-binding active loop peptide variant |
Research characteristics
Sclerostin Block
Inhibits negative bone regulation pathways
Bone Hypertrophy
Accelerates structural density markers
Experimental
Highly requested skeletal recovery target
Ambient Stability
Demands highly precise cold storage profiles
Reconstitution
Use the interactive reconstitution calculator to convert vial size (mg), bacteriostatic water volume (ml) and target dose (mcg) into a syringe draw on a standard 100-unit insulin syringe. Open the dosage calculator.
Related immune, solvents & others compounds
Tuftsin
Naturally occurring tetrapeptide phagocytosis-stimulating agent evaluated for immune defense.
Thymosin Alpha-1 (Immune)
Immunomodulating Thymosin Alpha-1 segment evaluated for systemic immune response optimization.
LL-37 (Immune Grade)
Cathelicidin immune segment researched for biofilm disruption and cellular pathogens defense.
KPV (Dermal & Immune)
Purified KPV tripeptide tailored for contact dermatitis and systemic cytokine balancing studies.
Thymopentin (Immune)
Thymopentin (TP-5) segment targeting lymphocyte maturation and cellular immune validation.
Splenopentin (SP-5)
Splenic peptide analog evaluated for T-cell subset balance and antibody optimization.